Cover Image
Market Research Report

Diagnostic Specialty Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Published by Transparency Market Research Product code 763122
Published Content info 175 Pages
Delivery time: 1-2 business days
Price
Back to Top
Diagnostic Specialty Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Published: December 13, 2018 Content info: 175 Pages
Description

Title:
Diagnostic Specialty Antibodies Market (Antibody Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies; Application - Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, Infectious Disease Diagnostics; End user - Hospitals, Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global Diagnostic Specialty Antibodies Market: Overview

Antibody is a blood protein produced in response to a specific antigen. An antibody is also known as immunoglobulin and is generally Y-shaped in structure. Advances in genetic engineering have made antibodies, especially monoclonal antibodies, more robust and efficacious as these increase the binding capacity to any type of specific antigen and are quite effective as a diagnostics tool to evaluate the various infectious diseases. However, demand for Diagnostic Specialty Antibodies is anticipated to decline during the forecast period owing to failure of antibodies in rapid diagnostic test for routine diagnosis and high cost of monoclonal antibodies.

The global diagnostic specialty antibodies market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on antibody type, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global diagnostic specialty antibodies market.

Global Diagnostic Specialty Antibodies Market: Key Segments

In terms of antibody type, the global diagnostic specialty antibodies market has been segmented into monoclonal antibodies, polyclonal antibodies, and recombinant polyclonal antibodies. Based on application, the market has been classified into hepatitis diagnosis, tuberculosis diagnostics, dengue diagnostics, oncology diagnostics, HIV diagnostics, infectious disease diagnostics, and others. In terms of end-user, the global diagnostic specialty antibodies market has been categorized into hospitals, diagnostic laboratories, and others. The market has been analyzed based on price variations, technology trend, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Diagnostic Specialty Antibodies Market: Regional Outlook

Geographically, the global diagnostic specialty antibodies market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa and GCC Countries). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the report are F. Hoffmann-La Roche AG, Sanofi, Abbott Laboratories, Abcam plc, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., and Aytu BioScience, Inc., among others.

The global diagnostic specialty antibodies market has been segmented as follows:

Global Diagnostic Specialty Antibodies Market, by Antibody Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Polyclonal Antibodies

Global Diagnostic Specialty Antibodies Market, by Application

  • Hepatitis Diagnosis
  • Tuberculosis Diagnostics
  • Dengue Diagnostics
  • Oncology Diagnostics
  • HIV Diagnostics
  • Infectious Disease Diagnostics
  • Others

Global Diagnostic Specialty Antibodies Market, by End-user

  • Hospitals
  • Diagnostic Laboratories
  • Others

Global Diagnostic Specialty Antibodies Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa
Table of Contents

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights
  • 1.3. Assumptions and Acronyms Used

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Key Industry Evolution/Developments
  • 4.3. Overview: Global Diagnostic Specialty Antibodies Market
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
      • 4.4.1.1. Surge in government investment in diagnostic health care
      • 4.4.1.2. Increase in launch of new, innovative biologic diagnostic kits
    • 4.4.2. Restraints
      • 4.4.2.1. Failure of antibodies in rapid diagnostic test for routine diagnosis
      • 4.4.2.2. High cost of monoclonal antibodies
    • 4.4.3. Opportunities
      • 4.4.3.1. Expansion into emerging markets
  • 4.5. Technological Assessment
  • 4.6. Pipeline Analysis: Diagnostic Specialty Antibody
  • 4.7. Patent Filling Details of Various Diagnostic Antibody
  • 4.8. Regulatory Framework

5. Global Diagnostic Specialty Antibodies Market, by Antibody Type

  • 5.1. Introduction and Definitions
  • 5.2. Key Findings
  • 5.3. Global Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
  • 5.4. Global Diagnostic Specialty Antibodies Market Size & Forecast, by Antibody Type
    • 5.4.1. Monoclonal Antibodies
    • 5.4.2. Polyclonal Antibodies
    • 5.4.3. Recombinant Polyclonal Antibodies
  • 5.5. Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type

6. Global Diagnostic Specialty Antibodies Market, by Application

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings
  • 6.3. Global Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
    • 6.3.1. Global Diagnostic Specialty Antibodies Market Size & Forecast, by Application
    • 6.3.2. Hepatitis Diagnosis
    • 6.3.3. Tuberculosis Diagnostics
    • 6.3.4. Dengue Diagnostics
    • 6.3.5. Oncology Diagnostics
    • 6.3.6. HIV Diagnostics
    • 6.3.7. Infectious Disease Diagnostics
    • 6.3.8. Others
  • 6.4. Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application

7. Global Diagnostic Specialty Antibodies Market, by End-user

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings
  • 7.3. Global Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
    • 7.3.1. Global Diagnostic Specialty Antibodies Market Size & Forecast, by End-user
    • 7.3.2. Hospitals
    • 7.3.3. Diagnostic Laboratories
    • 7.3.4. Others
  • 7.4. Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

8. Global Diagnostic Specialty Antibodies Market, by Region

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings
  • 8.3. Global Diagnostic Specialty Antibodies Market Value Share Analysis, by Region
    • 8.3.1. Global Diagnostic Specialty Antibodies Market Size & Forecast, by Region
    • 8.3.2. North America
    • 8.3.3. Europe
    • 8.3.4. Asia Pacific
    • 8.3.5. Latin America
    • 8.3.6. Middle East & Africa
  • 8.4. Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Region

9. North America Diagnostic Specialty Antibodies Market, by Region

  • 9.1. Key Findings
  • 9.2. North America Diagnostic Specialty Antibodies Market Value Share Analysis, by Country
  • 9.3. North America Diagnostic Specialty Antibodies Market Value Forecast, by Country
    • 9.3.1. U.S.
    • 9.3.2. Country
  • 9.4. North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country
  • 9.5. North America Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
  • 9.6. North America Diagnostic Specialty Antibodies Market Value Forecast, by Antibody Type
    • 9.6.1. Monoclonal Antibodies
    • 9.6.2. Polyclonal Antibodies
    • 9.6.3. Recombinant Polyclonal Antibodies
  • 9.7. North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type
  • 9.8. North America Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
  • 9.9. North America Diagnostic Specialty Antibodies Market Value Forecast, by Application
    • 9.9.1. Hepatitis Diagnosis
    • 9.9.2. Tuberculosis Diagnostics
    • 9.9.3. Dengue Diagnostics
    • 9.9.4. Oncology Diagnostics
    • 9.9.5. HIV Diagnostics
    • 9.9.6. Infectious Disease Diagnostics
    • 9.9.7. Others
  • 9.10. North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application
  • 9.11. North America Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
  • 9.12. North America Diagnostic Specialty Antibodies Market Value Forecast, by End-user
    • 9.12.1. Hospitals
    • 9.12.2. Diagnostic Laboratories
    • 9.12.3. Others
  • 9.13. North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

10. Europe Diagnostic Specialty Antibodies Market, by Region

  • 10.1. Key Findings
  • 10.2. Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region
  • 10.3. Europe Diagnostic Specialty Antibodies Market Value Forecast, by Country/Sub-region
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Spain
    • 10.3.5. Italy
    • 10.3.6. Rest of Europe
  • 10.4. Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region
  • 10.5. Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
  • 10.6. Europe Diagnostic Specialty Antibodies Market Value Forecast, by Antibody Type
    • 10.6.1. Monoclonal Antibodies
    • 10.6.2. Polyclonal Antibodies
    • 10.6.3. Recombinant Polyclonal Antibodies
  • 10.7. Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type
  • 10.8. Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
  • 10.9. Europe Diagnostic Specialty Antibodies Market Value Forecast, by Application
    • 10.9.1. Hepatitis Diagnosis
    • 10.9.2. Tuberculosis Diagnostics
    • 10.9.3. Dengue Diagnostics
    • 10.9.4. Oncology Diagnostics
    • 10.9.5. HIV Diagnostics
    • 10.9.6. Infectious Disease Diagnostics
    • 10.9.7. Others
  • 10.10. Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application
  • 10.11. Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
  • 10.12. Europe Diagnostic Specialty Antibodies Market Value Forecast, by End-user
    • 10.12.1. Hospitals
    • 10.12.2. Diagnostic Laboratories
    • 10.12.3. Others
  • 10.13. Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

11. Asia Pacific Diagnostic Specialty Antibodies Market, by Region

  • 11.1. Key Findings
  • 11.2. Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region
  • 11.3. Asia Pacific Diagnostic Specialty Antibodies Market Value Forecast, by Country/Sub-region
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia & New Zealand
    • 11.3.5. Rest of Asia Pacific
  • 11.4. Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region
  • 11.5. Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
  • 11.6. Asia Pacific Diagnostic Specialty Antibodies Market Value Forecast, by Antibody Type
    • 11.6.1. Monoclonal Antibodies
    • 11.6.2. Polyclonal Antibodies
    • 11.6.3. Recombinant Polyclonal Antibodies
  • 11.7. Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type
  • 11.8. Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
  • 11.9. Asia Pacific Diagnostic Specialty Antibodies Market Value Forecast, by Application
    • 11.9.1. Hepatitis Diagnosis
    • 11.9.2. Tuberculosis Diagnostics
    • 11.9.3. Dengue Diagnostics
    • 11.9.4. Oncology Diagnostics
    • 11.9.5. HIV Diagnostics
    • 11.9.6. Infectious Disease Diagnostics
    • 11.9.7. Others
  • 11.10. Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application
  • 11.11. Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
  • 11.12. Asia Pacific Diagnostic Specialty Antibodies Market Value Forecast, by End-user
    • 11.12.1. Hospitals
    • 11.12.2. Diagnostic Laboratories
    • 11.12.3. Others
  • 11.13. Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

12. Latin America Diagnostic Specialty Antibodies Market, by Region

  • 12.1. Key Findings
  • 12.2. Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region
  • 12.3. Latin America Diagnostic Specialty Antibodies Market Value Forecast, by Country/Sub-region
    • 12.3.1. Brazil
    • 12.3.2. Mexico
    • 12.3.3. Rest of Latin America
  • 12.4. Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region
  • 12.5. Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
  • 12.6. Latin America Diagnostic Specialty Antibodies Market Value Forecast, by Antibody Type
    • 12.6.1. Monoclonal Antibodies
    • 12.6.2. Polyclonal Antibodies
    • 12.6.3. Recombinant Polyclonal Antibodies
  • 12.7. Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type
  • 12.8. Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
  • 12.9. Latin America Diagnostic Specialty Antibodies Market Value Forecast, by Application
    • 12.9.1. Hepatitis Diagnosis
    • 12.9.2. Tuberculosis Diagnostics
    • 12.9.3. Dengue Diagnostics
    • 12.9.4. Oncology Diagnostics
    • 12.9.5. HIV Diagnostics
    • 12.9.6. Infectious Disease Diagnostics
    • 12.9.7. Other Diagnostics
  • 12.10. Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application
  • 12.11. Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
  • 12.12. Latin America Diagnostic Specialty Antibodies Market Value Forecast, by End-user
    • 12.12.1. Hospitals
    • 12.12.2. Diagnostic Laboratories
    • 12.12.3. Others
  • 12.13. Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

13. Middle East & Africa Diagnostic Specialty Antibodies Market, by Region

  • 13.1. Key Findings
  • 13.2. Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region
  • 13.3. Middle East & Africa Diagnostic Specialty Antibodies Market Value Forecast, by Country/Sub-region
    • 13.3.1. South Africa
    • 13.3.2. GCC Countries
    • 13.3.3. Rest of Middle East & Africa
  • 13.4. Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region
  • 13.5. Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
  • 13.6. Middle East & Africa Diagnostic Specialty Antibodies Market Value Forecast, by Antibody Type
    • 13.6.1. Monoclonal Antibodies
    • 13.6.2. Polyclonal Antibodies
    • 13.6.3. Recombinant Polyclonal Antibodies
  • 13.7. Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type
  • 13.8. Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
  • 13.9. Middle East & Africa Diagnostic Specialty Antibodies Market Value Forecast, by Application
    • 13.9.1. Hepatitis Diagnosis
    • 13.9.2. Tuberculosis Diagnostics
    • 13.9.3. Dengue Diagnostics
    • 13.9.4. Oncology Diagnostics
    • 13.9.5. HIV Diagnostics
    • 13.9.6. Infectious Disease Diagnostics
    • 13.9.7. Others
  • 13.10. Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application
  • 13.11. Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
  • 13.12. Middle East & Africa Diagnostic Specialty Antibodies Market Value Forecast, by End-user
    • 13.12.1. Hospitals
    • 13.12.2. Diagnostic Laboratories
    • 13.12.3. Others
  • 13.13. Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

14. Company Profiles

    • 14.1.1. Abcam plc
      • 14.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.1.2. Financial Overview
      • 14.1.1.3. Product Portfolio
      • 14.1.1.4. SWOT Analysis
      • 14.1.1.5. Strategic Overview
    • 14.1.2. F. Hoffmann-La Roche AG
      • 14.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.2.2. Financial Overview
      • 14.1.2.3. Product Portfolio
      • 14.1.2.4. SWOT Analysis
      • 14.1.2.5. Strategic Overview
    • 14.1.3. Sanofi
      • 14.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.3.2. Financial Overview
      • 14.1.3.3. Product Portfolio
      • 14.1.3.4. SWOT Analysis
      • 14.1.3.5. Strategic Overview
    • 14.1.4. Abbott Laboratories
      • 14.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.4.2. Financial Overview
      • 14.1.4.3. Product Portfolio
      • 14.1.4.4. SWOT Analysis
      • 14.1.4.5. Strategic Overview
    • 14.1.5. Bio-Rad Laboratories, Inc.
      • 14.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.5.2. Financial Overview
      • 14.1.5.3. Product Portfolio
      • 14.1.5.4. SWOT Analysis
      • 14.1.5.5. Strategic Overview
    • 14.1.6. Boehringer Ingelheim International GmbH
      • 14.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.6.2. Financial Overview
      • 14.1.6.3. Product Portfolio
      • 14.1.6.4. SWOT Analysis
      • 14.1.6.5. Strategic Overview
    • 14.1.7. Agilent Technologies, Inc.
      • 14.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.7.2. Financial Overview
      • 14.1.7.3. Product Portfolio
      • 14.1.7.4. SWOT Analysis
      • 14.1.7.5. Strategic Overview
    • 14.1.8. Aytu BioScience, Inc.
      • 14.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.1.8.2. Financial Overview
      • 14.1.8.3. Product Portfolio
      • 14.1.8.4. SWOT Analysis
      • 14.1.8.5. Strategic Overview

List of Tables

  • Table 01: Pipeline Analysis of Diagnostic Specialty Antibodies (1/2)
  • Table 02: Pipeline Analysis of Diagnostic Specialty Antibodies (2/2)
  • Table 03: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Antibody Type, 2016-2026
  • Table 04: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Application, 2016-2026
  • Table 05: Global Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 06: Global Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 07: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • Table 08: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Antibody Type, 2016-2026
  • Table 09: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 10: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 11: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016-2026
  • Table 12: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Antibody Type, 2016-2026
  • Table 13: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 14: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 15: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Country/ Sub-Region, 2016-2026
  • Table 16: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Antibody Type, 2016-2026
  • Table 17: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 18: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 19: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 20: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Antibody Type, 2016-2026
  • Table 21: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 22: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 23: Middle East & Africa Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 24: Middle East & Africa Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Antibody Type, 2016-2026
  • Table 25: Middle East & Africa Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 26: Middle East & Africa Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016-2026

List of Figures

  • Figure 01: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
  • Figure 02: Market Snapshot of Global Diagnostic Specialty Antibodies Market
  • Figure 03: Market Opportunity Map, Revenue Share, by Antibody Type
  • Figure 04: Market Opportunity Map, Revenue Share, by Application
  • Figure 05: Recent Key Industry Events of Diagnostic Specialty Antibodies Market
  • Figure 06: Global Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, 2016-2026
  • Figure 07: Market Value Share, by End-user, 2017
  • Figure 08: Market Value Share, by Antibody Type, 2017
  • Figure 09: Market Value Share, by Region, 2017
  • Figure 10: Market Value Share, by Application, 2017
  • Figure 11: Patent Filling Details of Various Diagnostic Antibody
  • Figure 12: Patent Filling Details of Various Diagnostic Antibody
  • Figure 13: Patent Filling Details of Various Diagnostic Antibody
  • Figure 14: Global Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
  • Figure 15: Global Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018-2026
  • Figure 16: Global Monoclonal Antibodies Market Revenue
  • Figure 17: Global Polyclonal Antibodies Market Revenue
  • Figure 18: Global Recombinant Polyclonal Antibodies Market Revenue
  • Figure 19: Global Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
  • Figure 20: Global Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018-2026
  • Figure 21: Global Hepatitis Diagnosis Specialty Antibody Market Revenue
  • Figure 22: Global Tuberculosis Diagnostics Specialty Antibody Market Revenue
  • Figure 23: Global Dengue Diagnostics Specialty Antibody Market Revenue
  • Figure 24: Global Oncology Diagnostics Specialty Antibody Market Revenue
  • Figure 25: Global HIV Diagnostics Specialty Antibody Market Revenue
  • Figure 26: Global Infectious Disease Diagnostics Specialty Antibody Market Revenue
  • Figure 27: Global Others Specialty Antibody Market Revenue
  • Figure 28: Global Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
  • Figure 29: Global Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018-2026
  • Figure 30: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2016-2026
  • Figure 31: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2016-2026
  • Figure 32: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 32: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 33: Global Diagnostic Specialty Antibodies Market Value Share, by Region, 2018 and 2026
  • Figure 34: Global Diagnostic Specialty Antibodies Market Attractiveness, by Region, 2018-2026
  • Figure 35: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 36: North America Diagnostic Specialty Antibodies Market Value Share, by Country, 2018 and 2026
  • Figure 37: North America Diagnostic Specialty Antibodies Market Attractiveness, by Country, 2018-2026
  • Figure 38: North America Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
  • Figure 39: North America Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018-2026
  • Figure 40: North America Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
  • Figure 41: North America Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018-2026
  • Figure 42: North America Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
  • Figure 43: North America Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018-2026
  • Figure 44: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 45: Europe Diagnostic Specialty Antibodies Market Value Share, by Country/Sub-region, 2018-2026
  • Figure 46: Europe Diagnostic Specialty Antibodies Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 47: Europe Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
  • Figure 48: Europe Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018-2026
  • Figure 49: Europe Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
  • Figure 50: Europe Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018-2026
  • Figure 51: Europe Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
  • Figure 52: Europe Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018-2026
  • Figure 53: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 54: Asia Pacific Diagnostic Specialty Antibodies Market Value Share, by Country/Sub-region, 2018-2026
  • Figure 55: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 56: Asia Pacific Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
  • Figure 57: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018-2026
  • Figure 58: Asia Pacific Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
  • Figure 59: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018-2026
  • Figure 60: Asia Pacific Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
  • Figure 61: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018-2026
  • Figure 62: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 63: Latin America Diagnostic Specialty Antibodies Market Value Share, by Country/Sub-region, 2018-2026
  • Figure 64: Latin America Diagnostic Specialty Antibodies Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 65: Latin America Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
  • Figure 66: Latin America Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018-2026
  • Figure 67: Latin America Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
  • Figure 68: Latin America Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018-2026
  • Figure 69: Latin America Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
  • Figure 70: Latin America Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018-2026
  • Figure 71: Middle East & Africa Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 72: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share, by Country/Sub-region, 2018-2026
  • Figure 73: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 74: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
  • Figure 75: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018-2026
  • Figure 76: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
  • Figure 77: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018-2026
  • Figure 78: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
  • Figure 79: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018-2026
Back to Top